T

Trajan Group Holdings Ltd
ASX:TRJ

Watchlist Manager
Trajan Group Holdings Ltd
ASX:TRJ
Watchlist
Price: 0.65 AUD Market Closed
Market Cap: AU$99.2m

Net Margin

-2.7%
Current
Improving
by 3%
vs 3-y average of -5.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2.7%
=
Net Income
AU$-4.5m
/
Revenue
AU$166.5m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2.7%
=
Net Income
AU$-4.5m
/
Revenue
AU$166.5m

Peer Comparison

Country Company Market Cap Net
Margin
AU
Trajan Group Holdings Ltd
ASX:TRJ
99m AUD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
166.4B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.4B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.7B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.3B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.9B EUR
Loading...

Market Distribution

In line with most companies in Australia
Percentile
60th
Based on 4 004 companies
60th percentile
-2.7%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Trajan Group Holdings Ltd
Glance View

Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. The firm is developing and manufacturing analytical science instruments, devices and solutions used in the analysis of biological, food and environmental samples. The firm is focused on serving life science, biopharmaceutical, and analytical companies in the United States, Australia, Europe, and Asia. The firm is operating in two segments, which includes Analytical Products and Life Science Solutions. Its Analytical Products include Metal syringes, Gas tight syringes, eVol, liquid extraction (uLLE), Electrokinetic extraction (EkE), Ferrules, Microfluidics, Emitter tips, Septa and caps and Porous polymer monoliths. Its Life Science Solutions include Dispensing syringes, Microscope slides, Coverslips, Slide and cassette storage, Liquid powder dispensing, Infusion automation, hemaPEN, Microbiopsy and Hummingbird. The company also offers micro-biopsy device for skin sampling, including Mitra device.

TRJ Intrinsic Value
1.26 AUD
Undervaluation 48%
Intrinsic Value
Price
T
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-2.7%
=
Net Income
AU$-4.5m
/
Revenue
AU$166.5m
What is Trajan Group Holdings Ltd's current Net Margin?

The current Net Margin for Trajan Group Holdings Ltd is -2.7%, which is above its 3-year median of -5.6%.

How has Net Margin changed over time?

Over the last 3 years, Trajan Group Holdings Ltd’s Net Margin has decreased from 1% to -2.7%. During this period, it reached a low of -17.8% on Dec 31, 2024 and a high of 2.9% on Dec 31, 2022.

Back to Top